IV treatment for MS clears another NICE hurdle
An intravenous drug that is taken once a year over two years looks set to gain official approval as a new treatment option for multiple sclerosis.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
Customised email alerts straight to your inbox (over 30 alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units